Viewing Study NCT03275103


Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2025-12-27 @ 7:36 AM
Study NCT ID: NCT03275103
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-17
First Post: 2017-09-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
Sponsor: Genentech, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module